Abbott introduces single-dose formulation of carbetocin in India

Drug major Abbott on Tuesday said it has launched room-temperature-stable, single-dose formulation of carbetocin in India to help in the prevention of postpartum haemorrhage (PPH). PPH refers to excessive blood loss of 500 ml or more after vaginal delivery and 1,000 ml or more after a caesarean procedure, within 24 hours of childbirth. Although preventable, … Read more

Abbott is more than 100 years old in India

Abbott, one of the most admired healthcare global company is also one of the oldest in India. It was established in India in 1910. When I first read about it, I couldn’t believe it and hence thought of sharing. Also for ease of reference, Abbott originally an American Company was founded in 1888. i.e., 22 … Read more

Pharmaceutical firms turn focus to inhalation products for Covid-19

After injectables and oral solid drugs, now pharmaceutical firms are focusing on coming up with re-purposed inhalation products for Covid-19. While drug major Lupin is working on a remdesivir powder for inhalation, Mumbai-based Glenmark has tied up with a Canadian Biotech firm for Nitric Oxide nasal spray that reduces Sars-CoV-2 viral load and thus transmission. … Read more

Tech Mahindra expects to begin trials for planned COVID drug in 3-4 months

After receiving the patent for a particular molecule, according to a senior official. Markers Lab, the research and development arm of the IT company, is working on developing the drug. The company along with Reagene Biosciences has filed for the patent for a molecule that can be used to develop a drug against coronavirus. “We … Read more

Sanofi and GSK COVID-19 vaccine candidate demonstrates strong immune responses across all adult age groups in Phase 2 trial

Sanofi and GSK COVID-19 vaccine candidate demonstrates strong immune responses across all adultage groups in Phase 2 trial Adjuvanted recombinant COVID-19 vaccine candidate triggered strong neutralizing antibody responses in all adult age groups High immune response after a single dose in patients with prior infection shows strong booster potential Global Phase 3 study expected to … Read more

Over 300 pharma, healthcare companies eligible for new Covid loans

As many as 354 Crisil-rated companies, predominantly pharmaceutical firms and hospitals, with an aggregate bank exposure of Rs 40,000 crore will be eligible for Covid loans from lenders under RBI’s liquidity facility.   Though pharmaceutical firms account for 68 per cent of rated bank exposure, hospitals (about 24 per cent of rated exposure) are likely … Read more